Wendy Hartogensis

CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART

Rémi Fromentin, Wendy Bakeman, Mariam B. Lawani et al. · PLoS Pathogens · 2016 · 424 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Antiretroviral Therapy Initiated Within 6 Months of HIV Infection Is Associated With Lower T-Cell Activation and Smaller HIV Reservoir Size

Vivek Jain, Wendy Hartogensis, Peter Bacchetti et al. · The Journal of Infectious Diseases · 2013 · 330 citations · Full text

Life Sciences, Immunology, Adaptive Immunity +15

The Effect of Same-Day Observed Initiation of Antiretroviral Therapy on HIV Viral Load and Treatment Outcomes in a US Public Health Setting

Christopher D. Pilcher, Clarissa Ospina-Norvell, Aditi Dasgupta et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2016 · 256 citations · Full text

Public Health, Pharmacotherapy, Hiv Control +15

Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study

Julian Elliott, James McMahon, Christina C. Chang et al. · The Lancet HIV · 2015 · 247 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +9

The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies

Golnaz Namazi, Jesse Fajnzylber, Evgenia Aga et al. · The Journal of Infectious Diseases · 2018 · 205 citations · Full text

Public Health, Infectious Disease Control, Infectious Diseases +13